P. Musto
Impact in
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
- Hematology top 10%
- Multiple Myeloma Research and Treatments
Papers in
- Hematology 12
- Multiple Myeloma Research and Treatments 10
- Oncology 8
- Cancer Treatment and Pharmacology 4
- HER2/EGFR in Cancer Research 2
- Peptidase Inhibition and Analysis 2
- Co-authors
- Narasimhan P. Agaram (1 shared paper)Thomas M. Ulbright (1 shared paper)Muhammad T. Idrees (1 shared paper)Eyas M. Hattab (1 shared paper)Kurt Hodges (1 shared paper)Sunil Badve (1 shared paper)Rutika Mehta (1 shared paper)Kenneth C. Anderson (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Clinical Cancer Research (1 paper)Modern Pathology (1 paper)Bone Marrow Transplantation (1 paper)Leukemia Research (1 paper)
- Partner nations
- United States
In The Last Decade
P. Musto
18 papers receiving 221 citations
Peers
Comparison fields: 5 of 41
- Genetics 98
- Hematology 79
- Pathology and Forensic Medicine 115
- Cancer Research 35
- Dermatology 18
Countries citing papers authored by P. Musto
This map shows the geographic impact of P. Musto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Musto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Musto more than expected).
Fields of papers citing papers by P. Musto
This network shows the impact of papers produced by P. Musto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Musto. The network helps show where P. Musto may publish in the future.
Co-authors
The 25 scholars most cited alongside P. Musto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 89 | |
| 2 | 2011 | 84 | |
| 3 | TWO DOSE-INTENIVE MELPHALAN REGIMENS (100 MG/M2 VERSUS 200 MG/M2) IN MULTIPLE MYELOMA PATIENTS | 2003 | 12 |
| 4 | 2002 | 8 | |
| 5 | 1994 | 7 | |
| 6 | Secondary malignancies in elderly myeloma patients | 2011 | 6 |
| 7 | 2004 | 6 | |
| 8 | [An unusual case of postoperative mechanical obstruction of the upper respiratory tract in a child]. | 1977 | 3 |
| 9 | 2010 | 2 | |
| 10 | 2010 | 2 | |
| 11 | Autologous stem cell transplantation (ASCT) vs ASCT followed by reduced-intensity conditioning allogeneic SCT with identical sibling donor in previously untreated multiple myeloma: preliminary analysis of a prospective controlled trial by the EBMT | 2008 | 1 |
| 12 | 2019 | 1 | |
| 13 | IN MYELOMA PATIENTS TREATED WITH MELPHALAN 100mg/m2 OR MELPHALAN 200mg/m2 OUTCOME IS NOT SIGNIFICANTLY DIFFERENT | 2000 | 1 |
| 14 | Low-dose thalidomide and dexamethasone improves survival in advanced multiple myeloma | 2002 | 1 |
| 15 | 2010 | 1 | |
| 16 | INTERMEDIATE-DOSE MELPHALAN (100MG/M2), THALIDOMIDE, DEXAMETHASONE AND STEM CELL SUPPORT IN PATIENTS WITH REFRACTORY OR RELAPSED MYELOMA | 2006 | 1 |
| 17 | 2011 | 1 | |
| 18 | A RANDOMIZED PHASE II STUDY (GISL-MM03 TRIAL) WITH ORAL MELPHALAN plus PREDNISONE (MP) VERSUS MELPHALAN, plus PREDNISONE plus THALIDOMIDE (MPT) FOR NEWLY DIAGNOSED ELDERLY PATIENTS WITH MULTIPLE MYELOMA | 2009 | 1 |
About P. Musto
P. Musto is a scholar working on Hematology, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Infectious Diseases, having authored 18 papers that have together received 227 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (10 papers), Cancer Treatment and Pharmacology (4 papers), Cancer therapeutics and mechanisms (4 papers), HER2/EGFR in Cancer Research (2 papers), HIV/AIDS drug development and treatment (2 papers), Peptidase Inhibition and Analysis (2 papers), Pharmacological Effects and Toxicity Studies (1 paper) and Hemoglobinopathies and Related Disorders (1 paper). The work is most often cited by research in Genetics (98 citations), Hematology (79 citations), Pathology and Forensic Medicine (115 citations), Cancer Research (35 citations) and Dermatology (18 citations). P. Musto has collaborated with scholars based in United States. Frequent co-authors include Narasimhan P. Agaram, Thomas M. Ulbright, Muhammad T. Idrees, Eyas M. Hattab, Kurt Hodges, Sunil Badve, Rutika Mehta, Kenneth C. Anderson, Christopher J. Patterson and Andrew R. Branagan. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Modern Pathology, Bone Marrow Transplantation and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.